Histone deacetylases and their inhibitors in inflammatory diseases

被引:18
作者
Zhang, Sen-Yu [1 ]
Zhang, Li-Ying [1 ]
Wen, Ri [1 ]
Yang, Ni [1 ]
Zhang, Tie-Ning [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Pediat, PICU, Shenyang 110004, Peoples R China
关键词
Histone deacetylase; Inflammation; Disease; Drugs; Review; SUBEROYLANILIDE HYDROXAMIC ACID; VERSUS-HOST-DISEASE; ACUTE LUNG INJURY; HDAC INHIBITORS; CLASS-I; RHEUMATOID-ARTHRITIS; EPIGENETIC ENZYMES; LIVER-FAILURE; EXPRESSION; TRICHOSTATIN;
D O I
10.1016/j.biopha.2024.117295
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Despite considerable research efforts, inflammatory diseases remain a heavy burden on human health, causing significant economic losses annually. Histone deacetylases (HDACs) play a significant role in regulating inflammation (via histone and non-histone protein deacetylation) and chromatin structure and gene expression regulation. Herein, we present a detailed description of the different HDACs and their functions and analyze the role of HDACs in inflammatory diseases, including pro-inflammatory cytokine production reduction, immune cell function modulation, and anti-inflammatory cell activity enhancement. Although HDAC inhibitors have shown broad inflammatory disease treatment potentials, their clinical applicability remains limited because of their non-specific effects, adverse effects, and drug resistance. With further research and insight, these inhibitors are expected to become important tools for the treatment of a wide range of inflammatory diseases. This review aims to explore the mechanisms and application prospects of HDACs and their inhibitors in multiple inflammatory diseases.
引用
收藏
页数:18
相关论文
共 208 条
[41]   The safety profile of vorinostat suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studies [J].
Duvic, Madeleine ;
Dimopoulos, Meletios .
CANCER TREATMENT REVIEWS, 2016, 43 :58-66
[42]   Integrative regulation of physiology by histone deacetylase 3 [J].
Emmett, Matthew J. ;
Lazar, Mitchell A. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2019, 20 (02) :102-115
[43]   Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance [J].
Erin, Nuray ;
Grahovac, Jelena ;
Brozovic, Anamaria ;
Efferth, Thomas .
DRUG RESISTANCE UPDATES, 2020, 53
[44]   Infectious Diseases: Pathophysiology, Diagnostics and Prevention [J].
Esposito, Susanna .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (09)
[45]   Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders [J].
Falkenberg, Katrina J. ;
Johnstone, Ricky W. .
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (09) :673-691
[46]   Lower HDAC6 mRNA expression and promoter hypomethylation are associated with RA [J].
Fang, Tzu-Jung ;
Lin, Chia -Hui ;
Lin, Yuan-Zhao ;
Chiu, Min-HSi ;
Li, Ruei-Nian ;
Chan, Hua-Chen ;
Yeh, Yao-Tsung ;
Yen, Jeng-Hsien .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (08) :1431-1441
[47]   Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer's disease and Parkinson's disease [J].
Fang, Xin ;
Zhou, Xiaoting ;
Miao, Yuqing ;
Han, Yiwen ;
Wei, Jing ;
Chen, Tingtao .
AMB EXPRESS, 2020, 10 (01)
[48]   Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation [J].
Feng, Qiuqin ;
Su, Zhonglan ;
Song, Shiyu ;
Xu, Hui ;
Zhang, Bin ;
Yi, Long ;
Tian, Man ;
Wang, Hongwei .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 (03) :812-822
[49]   Pyruvate dehydrogenase complex and lactate dehydrogenase are targets for therapy of acute liver failure [J].
Ferriero, Rosa ;
Nusco, Edoardo ;
De Cegli, Rossella ;
Carissimo, Annamaria ;
Manco, Giuseppe ;
Brunetti-Pierri, Nicola .
JOURNAL OF HEPATOLOGY, 2018, 69 (02) :325-335
[50]   Impact of HDAC inhibitors on dendritic cell functions [J].
Frikeche, Jihane ;
Peric, Zinaida ;
Brissot, Eolia ;
Gregoire, Marc ;
Gaugler, Beatrice ;
Mohty, Mohamad .
EXPERIMENTAL HEMATOLOGY, 2012, 40 (10) :783-791